InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Champoux Jennifer. Director active across 1 company, notably Monte Rosa Therapeutics, Inc.. Cumulatively, 2 reports have been published. History available since 17 June 2026. The latest transaction was disclosed on 23 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations